# Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old

> **NCT00578734** · PHASE2 · COMPLETED · sponsor: **Windtree Therapeutics** · enrollment: 165 (actual)

## Conditions studied

- Acute Hypoxemic Respiratory Failure

## Interventions

- **DRUG:** Lucinactant
- **OTHER:** Sham Comparator

## Key facts

- **NCT ID:** NCT00578734
- **Lead sponsor:** Windtree Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2012-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578734, "Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00578734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*